Press Release

Aquaculture Vaccines Market to Grow with a CAGR of 7.75% through 2029

Prevalence of aquatic diseases is expected to drive the Global Aquaculture Vaccines Market growth in the forecast period, 2025-2029

 

According to TechSci Research report, “Aquaculture Vaccines Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2029F”, the Global Aquaculture Vaccines Market stood at USD 379.49 million in 2023 and is anticipated to grow with a CAGR of 7.75% through 2029. One of the primary drivers boosting the global aquaculture vaccines market is the increasing demand for seafood worldwide. Prevalence of Aquatic Diseases. Also.the prevalence of aquatic diseases is a significant factor driving the growth of the global aquaculture vaccines market. Aquatic diseases pose a substantial threat to the aquaculture industry, leading to significant economic losses, environmental impacts, and food security concerns. Infectious agents such as bacteria, viruses, parasites, and fungi can spread rapidly within aquaculture facilities, causing mass mortalities and reduced productivity among farmed fish and shellfish populations. Aquatic diseases can have devastating effects on aquaculture production, resulting in significant financial losses for producers and threatening the sustainability of aquaculture operations. Disease outbreaks can occur due to various factors, including overcrowding, poor water quality, environmental stressors, and the movement of infected animals or contaminated equipment. The globalization of trade and aquaculture practices has facilitated the spread of aquatic pathogens across geographic regions, further exacerbating disease risks.

In response to the prevalence of aquatic diseases, aquaculture producers increasingly recognize the importance of implementing effective disease prevention and control measures. Vaccination has emerged as a critical tool in disease management strategies, offering a proactive approach to safeguarding the health and productivity of farmed aquatic species. Aquaculture vaccines stimulate the immune system of fish and shellfish, helping them develop immunity against specific pathogens and reducing the likelihood of disease transmission within aquaculture facilities.  The demand for aquaculture vaccines is driven by the need to address the diverse range of aquatic diseases affecting different species and production systems. Common aquatic diseases include bacterial infections such as Vibrio and Aeromonas, viral infections like infectious salmon anemia (ISA) and viral hemorrhagic septicemia (VHS), and parasitic infestations such as sea lice. Aquaculture vaccines are developed to target these specific pathogens, offering tailored solutions for disease prevention and control.

 

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Aquaculture Vaccines Market

 

The Global Aquaculture Vaccines market is segmented into product, route of administration, application, regional distribution, and company.

Based on the product, the recombinant vaccine segment is anticipated to be the fastest-growing segment in the global aquaculture vaccines market during the forecast period. The increasing prevalence of infectious diseases in aquaculture is driving the demand for more effective and reliable vaccination solutions. As aquaculture operations expand to meet the rising global demand for seafood, the risk of disease outbreaks grows, necessitating advanced vaccine technologies. Recombinant vaccines, with their ability to induce strong and long-lasting immune responses, are well-suited to address these challenges. Advancements in biotechnology and genetic engineering are facilitating the development and production of recombinant vaccines. These technological innovations are making it easier and more cost-effective to produce vaccines at scale, thereby increasing their accessibility and adoption within the aquaculture industry. Regulatory approvals and support from government bodies for the use of recombinant vaccines in aquaculture are further propelling market growth. Growing awareness among aquaculture producers about the benefits of recombinant vaccines, coupled with the rising trend towards sustainable and responsible aquaculture practices, is expected to drive market demand. Producers are increasingly recognizing the importance of preventing disease through vaccination rather than relying on antibiotics, which can lead to resistance issues and environmental concerns..

The Asia Pacific market is poised to experience remarkable growth in the global aquaculture vaccines market over the forecast period.  This is due to factors such as increasing demand, a thriving aquaculture sector, government support initiatives, the presence of ample water resources in numerous countries, and a shift toward sustainable aquaculture practices. Governments and regulatory bodies in the Asia Pacific are increasingly focusing on promoting responsible aquaculture practices to ensure food security and environmental sustainability. This includes incentivizing the adoption of vaccination strategies to minimize the use of antibiotics and chemicals in aquaculture operations, aligning with global efforts to combat antimicrobial resistance and reduce environmental pollution.

 

Major companies operating in Global Aquaculture Vaccines Market are:

·         Zoetis Inc.

·         Phibro Animal Health Corporation

·         Elanco Animal Health Incorporated

·         Merck KGaA

·         KBNP Inc.

·         UNILINE GROUP FOR VETERINARY EQUIPMENT

·         Kyoto Biken Laboratories, Inc.

·         Nisseiken Co., Ltd.

·         Vaxxinova International BV

·         HIPRA SA

 

Download Free Sample Report

Customers can also request for 10% free customization on this report


“The Global Aquaculture Vaccines Market is poised for significant growth in the coming years. Governments and regulatory bodies worldwide are implementing policies and providing support to promote the use of vaccines in aquaculture. This includes funding for research and development, as well as streamlined approval processes for new vaccines. There is a growing awareness and focus on fish health and welfare within the aquaculture industry. Vaccines are seen as a key component in maintaining the health of farmed fish, leading to better growth rates and reduced mortality.” said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

Aquaculture Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines), By Route of Administration (Oral, Injected, Immersion & Spray), By Application (Bacterial, Viral, Parasitic) Region and Competition, 2019-2029F”, has evaluated the future growth potential of Global Aquaculture Vaccines Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Aquaculture Vaccines Market.

 

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]

Website: www.techsciresearch.com

Relevant News